Eptinezumab in Healthy Japanese Subjects
Clinical trial NCT04336449 · COMPLETED
Trial details
- NCT number
- NCT04336449
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2020-08-13
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.